Associated Papers
Transporter tandems: precise tools for normalizing active transporter in the plasma membrane.
Tschirka J et al.
The Biochemical Journal, 2020
Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition.
Zhou F et al.
Advanced Drug Delivery Reviews, 2017
OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease.
Lin Z et al.
Journal of Crohn's & Colitis, 2010
Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4).
Urban TJ et al.
Pharmacogenetics and Genomics, 2007
Japanese single nucleotide polymorphism database for 267 possible drug-related genes.
Iida A et al.
Cancer Science, 2006
Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population.
Kawasaki Y et al.
Journal of Pharmaceutical Sciences, 2004
An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis.
Tokuhiro S et al.
Nature Genetics, 2003
[SNP collection, pharmacogenomics, and the future of drug therapy].
Iida A et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy, 2002
Select a paper to view details